tACS for Amyloid-β Reduction in Alzheimer's Disease

Clinical trial NCT03290326 · COMPLETED

Trial details

NCT number: NCT03290326
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2017-11-27
Primary completion: 2019-05-14
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.